US Broker Ratings

Viemed Healthcare, Inc. (VMD) Stock Analysis: Exploring a 78% Upside Potential for Investors

Viemed Healthcare, Inc. (NASDAQ: VMD) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. Headquartered in Lafayette, Louisiana, Viemed specializes in providing home medical equipment..

NANO-X IMAGING LTD (NNOX) Stock Report: Exploring the 173% Potential Upside

Nano-X Imaging Ltd (NASDAQ: NNOX), a healthcare disruptor from Israel, is making waves in the medical devices industry with its cutting-edge digital X-ray technology. With a current market capitalization of..

Alpha Teknova, Inc. (TKNO) Stock Analysis: A Promising 118.98% Potential Upside Awaits Investors

Alpha Teknova, Inc. (TKNO), a key player in the healthcare sector, has been capturing investor attention with its innovative contributions to drug manufacturing, especially in the specialty and generic sub-industry...

Cytek Biosciences, Inc. (CTKB): Investor Outlook on a Potential 13.41% Upside

Cytek Biosciences, Inc. (NASDAQ: CTKB) is making waves in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $648.27 million, this U.S.-based company is strategically..

Cidara Therapeutics, Inc. (CDTX) Stock Analysis: Navigating Growth in the Biotech Sector with a 0.29% Potential Upside

Cidara Therapeutics, Inc. (NASDAQ: CDTX) stands at the forefront of the biotechnology sector with a focus on developing innovative therapies for critical medical conditions, notably invasive fungal infections and viral..

Erasca, Inc. (ERAS) Stock Analysis: Exploring a Potential 49% Upside in Precision Oncology

Erasca, Inc. (ERAS) has caught the attention of investors with its promising foray into the precision oncology sector. The San Diego-based biotechnology firm is at the forefront of developing innovative..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: A 14.70% Upside Potential Awaits Investors

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), a notable player in the biotechnology sector, is making waves with its promising pipeline and strong financial metrics. Headquartered in South San Francisco, California, Rigel..

Chevron Corporation (CVX) Stock Analysis: Exploring a 14.51% Upside Potential Amid Volatile Markets

As an energy giant with a market capitalization of $303.23 billion, Chevron Corporation (NYSE: CVX) remains a formidable player in the integrated oil and gas industry. Headquartered in Houston, Texas,..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Unlocking a 9.25% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG) stands out in the competitive healthcare sector with its specialized focus on providing essential services to medical care facilities. With a market capitalization of..

Artivion, Inc. (AORT) Stock Analysis: 10% Potential Upside in Medical Device Innovations

Artivion, Inc. (AORT), a prominent player in the healthcare sector specializing in medical devices, has captured the attention of investors with its robust growth prospects and innovative product offerings. Headquartered..

MiMedx Group, Inc (MDXG) Stock Analysis: A Biotechnology Gem with 73% Potential Upside

MiMedx Group, Inc. (NASDAQ: MDXG) is making waves in the biotechnology sector, capturing investor attention with its innovative approach to healthcare solutions. Specializing in the development and distribution of placental..

Neogen Corporation (NEOG) Stock Analysis: Is a 14.54% Potential Upside Worth Your Investment?

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector, particularly within the Diagnostics & Research industry, has been attracting attention from investors keen on capitalizing on its potential..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Strong Buy Ratings and Nearly 96% Upside Potential

Celldex Therapeutics, Inc. (NASDAQ: CLDX) has captured the attention of investors with its promising pipeline in the biotechnology space, particularly in treatments targeting severe inflammatory, allergic, and autoimmune diseases. As..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Potential 152% Upside Captivates Investors

Investors eyeing the biotech sector might want to take a closer look at ARS Pharmaceuticals, Inc. (NASDAQ: SPRY). The company, known for its innovative approach in addressing severe allergic reactions,..

Kestra Medical Technologies (KMTS) Stock Analysis: Strong Revenue Growth Amidst Negative Earnings

Kestra Medical Technologies, Ltd. (KMTS), a burgeoning player in the healthcare sector, has carved out a niche in the medical instruments and supplies industry with its innovative approach to cardiovascular..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Unlocking a 27% Potential Upside in Biotech

Viridian Therapeutics, Inc. (NASDAQ: VRDN) is creating ripples across the biotechnology sector, an industry known for its groundbreaking innovations and volatile market dynamics. With a market cap of $3.1 billion,..

Aveanna Healthcare Holdings Inc (AVAH): Investor Outlook with a Promising 19.26% Potential Upside

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) stands as a significant player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.87 billion, Aveanna..

10x Genomics, Inc. (TXG) Investor Outlook: Navigating Growth and Challenges in Health Information Services

10x Genomics, Inc. (NASDAQ: TXG) stands as a distinctive player in the healthcare sector, specifically within the health information services industry. With its innovative technology platforms, 10x Genomics has carved..

Pulse Biosciences, Inc (PLSE) Investor Outlook: Exploring a 44.74% Potential Upside

As the healthcare sector continuously evolves with technological advancements, Pulse Biosciences, Inc (NASDAQ: PLSE) stands at the forefront of innovation with its cutting-edge bioelectric medicine solutions. Headquartered in Miami, Florida,..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Exploring a 14% Potential Upside in the Biotech Arena

Travere Therapeutics, Inc. (NASDAQ: TVTX), a biopharmaceutical company headquartered in San Diego, California, is making waves in the biotechnology sector. With a current market cap of $3.27 billion, the company..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds